Thomson Reuters | Thomson Reuters Partnering

Science

When you're looking to forge a partnership, you need to be absolutely sure that the drugs and companies you're targeting are the best potential match for your business.

Thomson Reuters Partnering TM offers you a comprehensive look at drugs currently in development, the companies developing them, and their market potential, so you can always structure the right deal with the right partner at the right time. For each potential partner and drug profiled, you can learn financial details, research interests, areas of therapeutic and technology expertise as well as existing licensing agreements, and much more.

HOT OFF THE PRESS

Download Thomson Reuters White Paper, Creating a Patient-based Forecast — a snapshot of the importance of patient-based forecasting in the current market conditions. This white paper looks at the role of forecasting and the factors to consider in developing a patient-based forecast.

Thomson Reuters Partnering is powered by IDdb, recognized as the world leader in drug pipeline information, and supported by the renowned expertise and objectivity of Thomson Reuters.

Essential knowledge for those seeking to in-license drugs or acquire companies. With Thomson Reuters Partnering you can:

Determine which assets to pursue.
Find the companies best able to develop and market your drugs.
Evaluate each opportunity quickly and efficiently, allowing you to focus on those with serious potential.
Review summaries of deals comparable to your own, giving you insight into the terms you can expect, and whether or not you're in the position to make the arrangement you want.
Stay up-to-date on the latest developments with custom alerting tools.

Thomson Reuters Partnering is a customizable product. Subscribe to the complete power-packed package or subscribe separately as individual tools for your specific needs:

Complete competitive assessment with Thomson Reuters Partnering Pipeline
Thomson Reuters Partnering Pipeline contains an unrivaled wealth of intelligence, history, and comparative data on the companies developing drugs and the drugs they are developing, so you can quickly find those that meet your scientific and business criteria.

Structure smarter deals with Thomson Reuters Partnering Deals
Thomson Reuters Partnering Deals takes the guesswork out of structuring deals in today's marketplace by allowing you to benchmark your deals, including terms and pricing, against comparable ones — before you sign the contracts.

Build confident forecasts with Thomson Reuters Partnering Forecast
Thomson Reuters Partnering Forecast provides the most accurate method available for assessing the sales potential of new drugs — by offering both consensus analyst market forecasts and transparent, patient-based forecasts for drugs that will compete with yours. Read more.

EVERYTHING YOU NEED TO KNOW, IN ONE PLACE.

Don't waste time sorting through data from a large number of potentially out-of-date sources with different indexing systems. Thomson Reuters Partnering makes it easy to navigate the ever-changing market climate with our strategically linked, user-friendly data, presented simply and clearly. Plus:

All data is assessed by senior scientists and managed by respected industry experts.
The comprehensive company and drug profiles cover the world's major pharmaceutical innovators, emerging companies, and non-profit research centers.
Thomson Reuters Partnering is powered by IDdb, recognized as the world leader in drug pipeline information, and supported by the renowned expertise and objectivity of Thomson Reuters.

Find out more about Thomson Reuters Partnering.

Contact Us

North America

Tel: +1 800.336.4474
Tel: +1 215.386.0100
Fax: +1 215.386.2911

Europe, Middle East & Africa

Tel: +44 20.7433.4000

Latin America

Brazil: +55 11 8370 9845
Other Countries: +1 215 823 5674

Japan

Tel: +81 3.5218.6500
Tel: 0800 888.8855 (free dial from Japan only)
Fax: +81 3.5218.7840

Asia Pacific

Australia & New Zealand:
+61 2 8587 7636
China: +86 10 5760 1200
India: +91 11 3044 6419
Korea: +82 2 2076 8100
South East Asia & Pakistan:
+65 6775 5088
Taiwan: +886 2 2503 3034